Origin Therapeutics Holdings Inc.

DB:U8B Stock Report

Market Cap: €979.2k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Origin Therapeutics Holdings Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Michael Galego

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership1.0%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Michael Galego (44 yo)

less than a year

Tenure

Mr. Michael Galego Serves as Interim CEO of Origin Therapeutics Holdings Inc. Since January 14, 2023. He serves as Director at Origin Therapeutics Holdings Inc. since September 2022. He has been an Observe...